• News
  • SAN DIEGO
  • Medical

Roche funds drug discovery projects at UC San Diego

With selection of its first three research projects, the new UC San Diego-Roche Extending Innovation Network program has been launched, according to a Monday release.

The program aims to accelerate the discovery of new drug therapies through research.

Under this partnership, faculty-initiated research projects are selected for funding from proposals solicited campus-wide on a planned biannual basis.

The program is headed by a joint-steering committee composed of two Roche researchers and two UCSD faculty members.

“We are very pleased about this exciting and innovative partnership, which strengthens UCSD Health Sciences’ strategic goal of broadly advancing our programs in drug discovery,” said David A. Brenner, vice chancellor for Health Sciences and dean of the UCSD School of Medicine.

The three initial two-year projects selected will use UCSD developed molecular technologies to gain understanding of the mechanisms of neuropsychiatric disease and leukemia, with the goal of developing treatments.

“This funding will help provide important new opportunities to translate basic discoveries and leading-edge technologies from UC San Diego’s research laboratories into needed therapies for patients,” said Palmer Taylor, associate vice chancellor for Health Sciences, and dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.